Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kineret in Intracerebral Haemorrhage
NCT03737344Phase 2Completed
- Start
- May 2019
- Primary completion
- Feb 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing IL-1Ra Kineret with IL-1Ra Placebo (2 arms). Primary endpoint: Oedema extension distance at 72 hours. Started May 2019; status: completed.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03737344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03737344.